RecruitingNANCT07052175

Prevention of Relapse in Behavioral Disorders: Study Protocol of a Randomized Control Trial

Sponsor: Clínica Nuestra Señora de la Paz

Trial Details

Condition	Substance-related Disorders
Intervention	Standard Multidisciplinary Treatment; Digital Monitoring Tool
Phase	NA
Status	Recruiting
Participants	150
Est. Completion	1 Dec 2026
Last Updated	14 May 2026

Primary Outcome

Biological Verification of Substance Use Relapse via Toxicological Testing: Urinalysis; Biological Verification of Substance Use Relapse via Toxicological Testing: Breath Alcohol Testing

Eligibility Criteria

Inclusion Criteria

Inclusion Criteria: * Understand spoken and written Spanish. * Signing the informed consent. * Own a smartphone with internet access and an iOS or Android operating system. Exclusion Criteria: * Institutionalized or incarcerated patients, or those anticipating imminent incarceration, without regular access to mobile phone use. * Refusal to install the mobile application. * Inability to understand and sign the informed consent form for any reason.

Trial Sites

Countries

Spain

View Registry Entry

Related Analysis

Digital Monitoring Tool for Addiction Relapse Prevention Enters Phase III Trial — Evidence-Based Approach to Substance Use Disorder Management

Spanish researchers are testing whether digital monitoring tools can improve relapse prevention in substance use disorders. The randomised trial compares standard multidisciplinary care with digitally-enhanced treatment, using biological verification to measure outcomes.

Read full article →

This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service